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Background
Multiplicity of benzodiazepine dependency complica-
tions force the addicts into a radical detoxification.
However, even motivated patients relapse right after
leaving a hospital ward. This may be due to premature
conclusion of detoxification.
Materials and methods
Presented data come from 200 cases. Detoxification fol-
lowed through 4 stages: long-acting benzodiazepine sub-
stitution, dose reduction, elimination, post-withdrawal
observation. Clinical state (CIWA-B, [1]) and the benzo-
diazepine serum level (standard immunoenzymatic
assay) were monitored. Patient’s dose reduction rate was
adjusted according to current intensity of withdrawal
symptoms. Continued clinical state monitoring followed
the final dose until total serum benzodiazepines
elimination.
Results
Uncorrelated of initial benzodiazepine levels and symp-
tom-adjusted dose-reduction rate among patients, elimi-
nation of the serum benzodiazepines was commonly
protracted, ranging 3 to 62 days after withdrawal.
Within this period, intensity of the withdrawal syn-
drome peaked several times, in varying combinations of
symptoms, until elimination completed (zero serum
level). Intensity often culminated 3-4 weeks after
withdrawal.
Conclusions
Underestimation of benzodiazepine elimination time and
resulting premature termination of post-withdrawal
observation may contribute to common post-detox
relapses in benzodiazepine-addicted patients. Peak-
intensity of withdrawal symptoms often occurs only
after the discharge from hospital ward. Monitoring of
the serum level prevents untimely discharge of detoxi-
fied patients. Accordingly, a positive benzodiazepine
serum level does not proove a recent benzodiazepine
use.
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